 So, I'm Mark Williams, I'm a PI at the Geisinger Emerge site, and some of you are probably looking at the next agenda item and saying, okay, why is this here? A little Admiral Stockdale moment, who am I and why am I here? But oh, those were the good old days in politics, weren't they? At any rate, I think one of the things that's been very forward thinking from the NHGRI-funded networks in consortia, not only Emerge Caesar, but also Ignite and others, has been the focus on implementation. And what can we do to actually move the things that we know work into routine clinical practice? And we've been talking about some of those issues already this morning, and we always come back to some of the very same concerns, which is do we have evidence of clinical utility, which is important from the clinician perspective, but is also important for the payer perspective. And so we've done active engagement with clinicians and with payers to be able to say, what sort of evidence could we be generating from these projects that would help us to move this forward? There's another way that we can also begin to think about how we can implement this into practice, and that's by utilizing quality metrics and taking those things where we really have extremely solid guideline level evidence and say, can we put this into our quality framework, which now is related to reimbursement and quality metrics? So we've been, over the last six months or so, the General Medical Medicine Working Group has been engaging with various representatives from quality groups, both nationally and internationally, to begin to talk about how we might be able to work in this space. And in particular, we've had some very fruitful discussions with the National Quality Forum, which is a leading group here in this country developing quality measures and working with a number of different organizations to say, how do we measure quality and use that to not only improve care, but also align reimbursement. And so I'm very pleased to introduce John Bernat from the National Quality Forum. And what he's going to do in his talk today is to provide some background about why quality is important. What the NQF does, and then talk about some exciting opportunities to partner with NQF to potentially move some quality metrics from genomics into practice. John.